000 01261 a2200361 4500
005 20250515012912.0
264 0 _c20060427
008 200604s 0 0 eng d
022 _a0090-8258
024 7 _a10.1016/j.ygyno.2005.11.043
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTai, Cheng-Jeng
245 0 0 _aRemission of a negative Her2/Neu overexpressive metastatic ovarian cancer patient by the single agent of trastuzumab as salvage therapy.
_h[electronic resource]
260 _bGynecologic oncology
_cApr 2006
300 _a184-5 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoplasm Metastasis
650 0 4 _aOvarian Neoplasms
_xmetabolism
650 0 4 _aReceptor, ErbB-2
_xbiosynthesis
650 0 4 _aSalvage Therapy
650 0 4 _aTrastuzumab
700 1 _aLo, Horng-Yuan
700 1 _aHsu, Chung-Huei
700 1 _aTai, Chen-Jei
700 1 _aLiu, Wei-Min
773 0 _tGynecologic oncology
_gvol. 101
_gno. 1
_gp. 184-5
856 4 0 _uhttps://doi.org/10.1016/j.ygyno.2005.11.043
_zAvailable from publisher's website
999 _c16030042
_d16030042